Learning Objectives
DESCRIPTION
Learning Objectives. PLATO Primary Efficacy End Point CV Death, MI, or Stroke. TRACER Primary End Point Composite of CV Death, MI, Stroke, Hospitalization for Ischemia, Urgent Revascularization. CHARISMA. Bleeding Trends in PCI.
1 / 35
Télécharger la présentation
Learning Objectives
An Image/Link below is provided (as is) to download presentation
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.
Content is provided to you AS IS for your information and personal use only.
Download presentation by click this link.
While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
During download, if you can't get a presentation, the file might be deleted by the publisher.
E N D
Presentation Transcript
TRACER Primary End PointComposite of CV Death, MI, Stroke, Hospitalization for Ischemia, Urgent Revascularization
Major Bleeding at Access SitesPooled Analysis of Bivalirudin Studies
ATLAS ACS 2—TIMI 51Mortality Benefit With Very-Low-Dose Rivaroxaban in STEMI Patients
TRILOGY-ACSPrimary Efficacy End Point to 30 Months (Age < 75 years)
TRILOGY-ACS Subgroup Analysis in Patients With Non-STEMI ACS
CHAMPION PHOENIX Primary Efficacy Outcomes at 48 Hours, MITT
More Related